Hunan Jingfeng Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000Y11
CNY
8.14
-0.53 (-6.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

  • NET SALES(9M) At CNY 304.72 MM has Grown at -17.68%
  • OPERATING CASH FLOW(Y) Lowest at CNY -2.75 MM
  • PRE-TAX PROFIT(Q) At CNY -10.67 MM has Fallen at -125.44%
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 4,115 Million (Small Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

8.18

stock-summary
Return on Equity

303.13%

stock-summary
Price to Book

83.55

Revenue and Profits:
Net Sales:
81 Million
(Quarterly Results - Jun 2025)
Net Profit:
-21 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
48.0%
0%
48.0%
6 Months
56.84%
0%
56.84%
1 Year
62.15%
0%
62.15%
2 Years
131.91%
0%
131.91%
3 Years
127.37%
0%
127.37%
4 Years
113.65%
0%
113.65%
5 Years
49.36%
0%
49.36%

Hunan Jingfeng Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-20.31%
EBIT Growth (5y)
14.30%
EBIT to Interest (avg)
-1.61
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
5.50
Sales to Capital Employed (avg)
0.98
Tax Ratio
3.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.30%
ROE (avg)
44.62%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
83.55
EV to EBIT
-140.26
EV to EBITDA
-777.52
EV to Capital Employed
9.99
EV to Sales
11.70
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
-7.12%
ROE (Latest)
303.13%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -17.61% vs -13.64% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -87.50% vs -104.20% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "81.40",
          "val2": "98.80",
          "chgp": "-17.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.40",
          "val2": "3.30",
          "chgp": "-233.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.80",
          "val2": "6.40",
          "chgp": "21.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-21.00",
          "val2": "-11.20",
          "chgp": "-87.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-134.20%",
          "val2": "-33.00%",
          "chgp": "-10.12%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -37.18% vs -22.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 170.07% vs -138.72% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "405.90",
          "val2": "646.10",
          "chgp": "-37.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.10",
          "val2": "-56.90",
          "chgp": "119.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "40.40",
          "val2": "42.00",
          "chgp": "-3.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "238.80",
          "val2": "-64.00",
          "chgp": "473.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "159.40",
          "val2": "-227.50",
          "chgp": "170.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-44.50%",
          "val2": "-160.90%",
          "chgp": "11.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
81.40
98.80
-17.61%
Operating Profit (PBDIT) excl Other Income
-4.40
3.30
-233.33%
Interest
7.80
6.40
21.88%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-21.00
-11.20
-87.50%
Operating Profit Margin (Excl OI)
-134.20%
-33.00%
-10.12%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -17.61% vs -13.64% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -87.50% vs -104.20% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
405.90
646.10
-37.18%
Operating Profit (PBDIT) excl Other Income
11.10
-56.90
119.51%
Interest
40.40
42.00
-3.81%
Exceptional Items
238.80
-64.00
473.12%
Consolidate Net Profit
159.40
-227.50
170.07%
Operating Profit Margin (Excl OI)
-44.50%
-160.90%
11.64%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -37.18% vs -22.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 170.07% vs -138.72% in Dec 2023

stock-summaryCompany CV
About Hunan Jingfeng Pharmaceutical Co., Ltd. stock-summary
stock-summary
Hunan Jingfeng Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available